Humana Inc. (HUM) Expands Beyond Insurance Into Healthcare Services

In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. Humana Inc. is one of them.

Humana Inc. (NYSE:HUM), a leading U.S. health insurer, specializes in Medicare Advantage plans, government-sponsored programs, and integrated healthcare services through its insurance and CenterWell health services segments. The company serves millions of Medicare Advantage members and emphasizes value-based care models and coordinated healthcare delivery.

In 2025, Humana Inc. (NYSE:HUM) raised its revenue guidance to at least $128 billion, driven by stronger-than-expected medical cost control and growth in its pharmacy business. This increase reflects the business’s operational resilience amid ongoing challenges in the healthcare insurance sector. A key factor has been the strategic refinement of Medicare Advantage offerings, including plan adjustments in higher-cost counties that reduced the medical loss ratio while retaining more individual members than anticipated.

Humana Inc. (NYSE:HUM)’s CenterWell health services division, encompassing primary care, pharmacy, and home health services, also contributed to growth. Notably, CenterWell Pharmacy’s partnership with Novo Nordisk to sell GLP-1 medications directly to consumers strengthened revenue and diversified HUM’s healthcare delivery capabilities. These initiatives demonstrate the firm’s commitment to expanding beyond traditional insurance into comprehensive healthcare solutions.

While we acknowledge the potential of HUM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure. None.